Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Zero based budgeting can help you allocate every dollar efficiently. Explore its benefits and drawbacks to see if it's right for your financial goals.
28,655 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Citigroup's Jane Fraser tops the 2026 Fortune Most Powerful Women list as 11 CFOs join the ranks, underscoring financ...
Ripple’s On-Demand Liquidity uses XRP to settle cross-border payments in seconds, cutting pre-funding needs and boost...
NUKZ is in focus as two pivotal drivers could redefine its trajectory: big-hyperscaler nuclear agreements and the rol...
A spike in pandemic-era scams swore of fast wealth, but the reality was a carefully hidden pyramid scheme. Learn how ...
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
Upscale AI closed a $190 million Series A-1, boosting total funding to $500 million and signaling a bold bid to becom...
Even with a tight budget, you can move toward financial independence. This guide lays out 5 roadblocks and a clear pl...
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
The SPDR S&P Metals & Mining ETF (XME) has surged toward a near-double over the past year, buoyed by gold and copper ...
Toyota announces a $3.6 billion investment to relocate Tacoma pickup production from Mexico to its San Antonio plant,...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...